In this segment of the Outsourced Pharma Live virtual event A New Age For Small Molecule Development, Conrad Wüllerm MSc, A short video from SCW for Pharma Podcast Series Episode 7 with Indranil Nandi, Chief Scientific Officer at Jubilant Radiopharma Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment to for players in the
A presentation by Dr Esther Schirrmacher This short course is designed to give an overview of GMP in Radiopharmaceutical In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma. A Look Back At The 2025 SNMMI Annual Meeting With AtomVie Global Radiopharma
AtomVie | Global Radiopharma Join the Nucleus RadioPharma Team - Quality System Manager Position Open
Webinar: Emerging Trends in Radiotherapeutics Radiopharmaceutical CDMO Market Explained | Nuclear Pharmacy Evergreen Theragnostics - Aerial Facility Video
Evergreen Theragnostics: Design & Construction of State-of-the-Art Radiopharmaceutical Facility This video highlights the collaboration and expertise involved with the creation of the first radiopharmaceutical manufacturing
Welcome to our channel, where news and job opportunities are brought to life! Our goal is to help job seekers to better understand Did you miss us live? This webinar is now available on demand. “What should providers and patients know about
Radiopharmaceuticals are drugs that contain radioactive isotopes linked to targeting molecules. They emit radiation that can be detected by imaging systems (for Take a look back at AtomVie's booth at the 2025 SNMMI Annual Meeting where we had an incredible experience connecting with Radiopharmaceutical CDMO/CMO Services Market Analysis and
The radiopharmaceutical sector, both here in Canada and globally, is seeing significant growth, with the global market for nuclear Finding CDMO Capacity In Radiopharmaceutical Drug Development Watch this webinar to learn about how the DRIVE-MRT solution enables the rationalization, design and optimization of targeted
Nucleus RadioPharma: Full-Service CDMO For Targeted Angstrom Technology helped a customer working in advanced radiopharmaceuticals research and development design and Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and
Radiopharm Theranostics (RAD) investor update webinar Nucleus RadioPharma offers premier full-service CDMO services to accelerate your radiopharmaceutical from research to market swiftly and safely. NorthStar's Radiopharmaceutical CDMO/CMO services span the spectrum of radioisotope drug development, from research and scale-up through commercialization.
Bruno Paquin, CTO, AtomVie Global Radiopharma - Benefits and Challenges of Radiopharmaceuticals Evergreen Virtual Facility Tour 2023 The intricate nature of radiopharmaceutical manufacturing, coupled with stringent regulatory requirements, has led to a surge in demand for
Cyclotron Facility & Nuclear Pharmacy Virtual Tour Recorded December 19, 2023 Organized by Nusano, this virtual key opinion leader (KOL) event focuses on the future of the
Research & Development Eckert & Ziegler's Boston Area Facility for Radiopharmaceutical Production and CDMO Work The Cyclotron Facility & Nuclear Pharmacy provides PET isotopes, radiochemicals, radiotracers and radiopharmaceuticals to the
Serena Williams shares her GLP-1 story in new role at Ro - NEWS 25/8/2025 [webinar] Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program Radiopharmaceutical CDMO Market Explained
In today's newsletter: - Tennis superstar #serenawilliams is partnering with #Ro to share her #glp1 story. - The UK government's Presenter: Bruno Paquin Title: CTO Company: AtomVie Global Radiopharma Presentation: Benefits and Challenges of NorthStar Medical Radioisotopes unveiled its new state-of-the-art radiopharmaceutical Contract Development & Manufacturing
Jubilant Pharmova Limited (formerly Jubilant Life Sciences Limited) is a company with a global presence that is involved in Advanced Radiopharmaceuticals Cleanroom
CDMO Services. Leverage our network of experts to bring your radiopharmaceutical candidate from preclinical development to commercial launch. CANM Radiopharmacy Course GMP in Radiopharmaceutical Production Importance of Just in Time Delivery for Radiopharmaceuticals
On the Talk Radioisotopes podcast, Jeff Jones of Oppenheimer & Company discusses the latest trends in the radiopharmaceutical NorthStar medical Radioisotopes hosts grand opening of new facility Radiopharmaceutical Drug Development in Canada
Nucleus RadioPharma July 2024 Webinar Radiopharmaceutical CDMO/CMO Services Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 7.0 Billion by the year
Radiopharmaceuticals market in next five years #podcast #talkradioisotopes Radiopharmaceutical CDMO/CMO CDMO Services For Targeted Radiotherapies | Nucleus RadioPharma
Lab 2 Radiopharmaceutical kit preparation Radiopharmaceutical CDMO Market Major players are improving growth by investing in more efficient manufacturing systems, ecological design, and
Episode 4 - Bruno Paquin, CEO of AtomVie Global Radiopharma [Latest] Global Radiopharmaceutical CDMO Market Size/Share
Join the Nucleus RadioPharma team as they answer a trending question: “What does Novartis's pursuit of a label expansion for The market is projected to reach $5.44 Billion USD by 2031, growing from USD 2.75 billion in 2023 (source). This represents a robust compound annual growth During the Grand Opening of our Wilmington, MA facility, Dr. Lutz Helmke and Jay Simon took some time to tour the premises and
(AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is proud to announce strategic collaborations with RLS Our radiopharmaceutical CDMO services support your drug from early development to commercial production, ensuring speed, efficiency, and regulatory compliance. Nucleus RadioPharma October 2024 Webinar
Radiopharmaceutical CDMO Market Explained - PharmaSource Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.
Jubilant Pharmova Limited